Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Ovarian Neoplasms × inavolisib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 24 Paclitaxel 20 Carboplatin 20 olaparib 19 Bevacizumab 13 Magnetic Resonance Spectroscopy 11 Gemcitabine 11 Taxes 10 Nivolumab 10 Cyclophosphamide 10 niraparib 9 Specimen Handling 8 Biopsy 8 liposomal doxorubicin 5 fludarabine 5 durvalumab 5 Surveys and Questionnaires 5 Immunoglobulin G 5 Doxorubicin 5 Disulfides 5 Cisplatin 5 Letrozole 4 Ipilimumab 4 palbociclib 3 oregovomab 3 cediranib 3 atezolizumab 3 X-Rays 3 Pemetrexed 3 Oxaliplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04931342 2026-03-10

BOUQUET

Hoffmann-La Roche

Phase 2 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡